XML 71 R27.htm IDEA: XBRL DOCUMENT v3.19.2
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Cash flows from operating activities:    
Net income $ 1,313 $ 896
Adjustments to reconcile net income to net cash flows from operating activities:    
Gains (losses) on marketable securities, net (62) (596)
Depreciation and amortization 1,472 1,466
Allowance for equity funds (70) (45)
Equity (income) loss, net of distributions 37 1
Changes in regulatory assets and liabilities 1 206
Deferred income taxes and amortization of investment tax credits 25 (264)
Other, net 23 26
Changes in other operating assets and liabilities, net of effects from acquisitions:    
Trade receivables and other assets (550) (226)
Derivative collateral, net (30) (5)
Pension and other postretirement benefit plans (41) (23)
Accrued property, income and other taxes, net (140) 174
Accounts payable and other liabilities 32 16
Net cash flows from operating activities 2,134 2,818
Cash flows from investing activities:    
Capital expenditures (2,750) (2,779)
Acquisitions, net of cash acquired (29) (107)
Purchases of marketable securities 190 209
Proceeds from sales of marketable securities 185 184
Equity method investments (211) (151)
Other, net 36 43
Net cash flows from investing activities (2,959) (3,019)
Cash flows from financing activities:    
Proceeds from BHE senior debt 0 2,176
Repayments of Unsecured Debt 0 (650)
Common stock purchases (293) (90)
Proceeds from subsidiary debt 3,464 1,313
Repayments of subsidiary debt (1,763) (1,082)
Net proceeds from (repayments of) short-term debt 64 (1,048)
Business acquisition, acquisition of remaining noncontrolling interest 0 131
Other, net (25) (23)
Net cash flows from financing activities 1,447 465
Effect of exchange rate changes 1 (3)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 623 261
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Start 883 1,283
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, End of Period $ 1,506 $ 1,544